Clinical Trials Browser

Phase 4 × Gynecologic × 1 year × Clear all

NCT06952660 2026-04-20

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Phase 4 Recruiting

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT05237947 2026-04-13

PRISMA

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

NCT05651282 2026-04-13

RESToRE

Phase 4 Completed

Endometrial Neoplasms

NCT07256912 2026-03-24

CervALONE

Phase 4 Not yet recruiting

Vaccine Effectiveness

NCT06412120 2026-03-16

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Phase 4 Recruiting

Ovarian Neoplasms

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

Phase 4 Not yet recruiting

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT04024254 2026-03-04

A Study of Serum Folate Levels in Patients Treated With Olaparib

Phase 4 Completed

10 enrolled 14 charts

BreastGynecologic

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

NCT05334706 2026-02-23

RIFT-HPV

Phase 4 Recruiting

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Phase 4 Not yet recruiting

Endometrial Neoplasms

NCT07412873 2026-02-17

PROVIDENCE

Phase 4 Not yet recruiting

Uterine Cervical Neoplasms

NCT06786429 2026-01-21

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Phase 4 Not yet recruiting

GastrointestinalGynecologic

Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Hepatitis B, Carcinoma, Hepatocellular, Gallstones

NCT07015957 2026-01-12

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

Phase 4 Active not recruiting

Cervical Cancer Prevention

NCT04145518 2025-12-12

MCUP

Phase 4 Completed

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

NCT06121401 2025-09-17

IOLANTHE

Phase 4 Active not recruiting

Carcinoma, Ovarian Epithelial

NCT07075250 2025-07-20

RIFOC003

Phase 4 Not yet recruiting

Platinum-resistant Ovarian Cancer (PROC)

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Phase 4 Not yet recruiting

Endometrial Neoplasms

NCT01932125 2025-06-26

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Phase 4 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT06972693 2025-05-15

PERSONA-Ovary

Phase 4 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms